Biovitrum AB and Discovery Partners International, Inc. form research alliance
Alliance Stockholm and San Diego. Biovitrum AB and Discovery Partners International, Inc. announced that they have entered into a drug discovery and development alliance. Biovitrum and Discovery Partners will work together to identify small molecule lead compounds suitable for advancing targets within the metabolic disease area.
Under the terms of this agreement, Biovitrum will get access to DPI´s comprehensive compound collection and its proprietary process and data management tools. Financial terms of the collaboration are not disclosed.
"We are impressed by DPI's integrated drug discovery approach and expect that this will add significant value to our ongoing lead discovery programs," said Mats Pettersson, Chief Executive Officer of Biovitrum.
"We are delighted to begin this collaboration with Biovitrum, and we are pleased to be working together on this promising new program," said Taylor Crouch, President & COO of Discovery Partners.
Other news from the department business & finance
